Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Mariel Metcalfe
  • September 23, 2020
  • Articles

Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma

Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma

Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and some key findings from recent studies conducted in Europe, USA and Japan. Published in pharmaphorum.

Most people know that asthma is a chronic long-term respiratory condition in which the lung’s airways become inflamed and narrowed, making it difficult for sufferers to breathe. It is also known that asthma causes wheezing and triggers a tightness in the chest. Medical researchers have identified that there are different types of asthma, and they respond differently to treatment. Severe asthma (SA) affects 15% of asthma suffers and usually appears in adults. Severe eosinophilic asthma (SEA) is rare and affects 40% of SA sufferers. 

read more »

  • Posted by Mariel Metcalfe
  • June 30, 2020
  • News

Research Partnership publishes new patient syndicated reports - Living with Ulcerative Colitis and Crohn’s Disease 2020

Research Partnership publishes new patient syndicated reports - Living with Ulcerative Colitis and Crohn’s Disease 2020

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the UC and CD patient journeys.   

read more »

  • Posted by Claire Fradet Aubignat
  • June 29, 2020
  • Articles

Not just another PSP: 5 top tips for evaluating your patient support programme

Not just another PSP: 5 top tips for evaluating your patient support programme

Evaluating PSPs before launch is critical. We present you with our top tips for conducting successful market research to ensure your PSP is successful and maximises value to your customers.

Did you know that, whilst there are a significant number of PSPs available to patients, only a small minority are actually used?  IMS (2015) found that 36 out of almost 200,000 mobile health apps comprised 50% of downloads - many of the rest must have very few users. So, a key challenge is to develop a PSP that is utilised, valued and has a definite real world impact on both the patient and HCP experience.

read more »

  • Posted by Mariel Metcalfe
  • May 26, 2020
  • News

Research Partnership publishes new patient syndicated reports - Living with Severe & Eosinophilic Asthma US, Japan, 2EU

Research Partnership publishes new patient syndicated reports - Living with Severe & Eosinophilic Asthma US, Japan, 2EU

Living with severe & eosinophilic asthma is a new syndicated report which offers valuable insights into patient attitudes and behaviour. The EU study was conducted amongst 118 patients with diagnosis and/or confirmed characteristics of severe asthma (SA) or eosinophilic asthma (EA) in France and Germany. The US study was conducted with 105 SA and EA patients. For both studies the methodologies consisted of 30-minute quantitative online interviews and a small sample of 30-minute qualitative add-on telephone interviews. The Japan report will also be available to purchase over the coming weeks. 

read more »

  • Posted by Mariel Metcalfe
  • April 27, 2020
  • News

Research Partnership publishes new patient Living with Anaemia in CKD EU & US reports

Research Partnership publishes new patient Living with Anaemia in CKD EU & US reports

Living with Anaemia in CKD is a new syndicated report which offers valuable insights into patient attitudes and behaviour. The EU study was conducted amongst 105 patients and caregivers in France, Germany, Italy and Spain. The US study was conducted with 61 CKD patients and caregivers. For both studies the methodologies consisted of 30-minute quantitative online and 30-minute qualitative telephone interviews.

read more »